Sci Show: Umbilical cord derived mesenchymal stem cell infusions safely reduce risk of death and quicken time to recovery for the severest COVID-19 patients, finds new randomized controlled double-blind trial. Patient survival at 1 month was 91% in the stem cell group versus 42% in the control group.

Tuesday, January 5, 2021

Umbilical cord derived mesenchymal stem cell infusions safely reduce risk of death and quicken time to recovery for the severest COVID-19 patients, finds new randomized controlled double-blind trial. Patient survival at 1 month was 91% in the stem cell group versus 42% in the control group.

https://ift.tt/2JJTSwG via /r/science https://ift.tt/2LodYNq

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)